December 20th 2024
The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.
October 11th 2024
Evonik won the CPHI Excellence in Pharma Award in the “Sustainability” category in recognition of its plant-based squalene, PhytoSquene, used in parenteral drug delivery applications.
August 30th 2024
The approach makes use of clinical mass spectrometers that are already available in hospitals around the world.
June 20th 2024
The companies have completed the expansion and qualification phase and now enter a stand-by phase for five years.
May 25th 2024
In an ASGCT Panel on nucleic acid- and cell-based vaccines in oncology, work on a personalized mRNA vaccine was highlighted.